Cambridge Investment Research Advisors’s First Trust Enhanced Short Maturity ETF FTSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$53.2M Sell
890,633
-125,579
-12% -$7.52M 0.12% 153
2026
Q1
$60.7M Buy
1,016,212
+43,000
+4% +$2.58M 0.16% 115
2025
Q4
$58.3M Buy
973,212
+87,479
+10% +$5.25M 0.15% 120
2025
Q3
$53.1M Sell
885,733
-166,562
-16% -$9.99M 0.15% 125
2025
Q2
$63M Sell
1,052,295
-32,955
-3% -$1.97M 0.19% 93
2025
Q1
$64.9M Buy
1,085,250
+46,237
+4% +$2.77M 0.22% 82
2024
Q4
$62.1M Sell
1,039,013
-134,333
-11% -$8.05M 0.21% 84
2024
Q3
$70.2M Sell
1,173,346
-214,837
-15% -$12.9M 0.24% 75
2024
Q2
$82.7M Buy
1,388,183
+56,415
+4% +$3.37M 0.31% 50
2024
Q1
$79.4M Sell
1,331,768
-167,267
-11% -$10M 0.31% 52
2023
Q4
$89.4M Sell
1,499,035
-82,882
-5% -$4.94M 0.38% 41
2023
Q3
$94M Sell
1,581,917
-214,329
-12% -$12.8M 0.44% 34
2023
Q2
$107M Sell
1,796,246
-145,890
-8% -$8.69M 0.49% 30
2023
Q1
$116M Buy
1,942,136
+377,998
+24% +$22.5M 0.57% 22
2022
Q4
$93M Buy
1,564,138
+340,322
+28% +$20.2M 0.48% 30
2022
Q3
$72.6M Buy
1,223,816
+693,214
+131% +$41.2M 0.41% 41
2022
Q2
$31.5M Buy
530,602
+213,296
+67% +$12.7M 0.17% 117
2022
Q1
$18.9M Buy
317,306
+35,224
+12% +$2.1M 0.09% 227
2021
Q4
$16.9M Buy
282,082
+53,025
+23% +$3.17M 0.08% 248
2021
Q3
$13.7M Sell
229,057
-18,042
-7% -$1.08M 0.07% 279
2021
Q2
$14.8M Sell
247,099
-205,940
-45% -$12.3M 0.07% 267
2021
Q1
$27.2M Buy
453,039
+224,183
+98% +$13.5M 0.15% 143
2020
Q4
$13.7M Sell
228,856
-40,092
-15% -$2.41M 0.08% 234
2020
Q3
$16.1M Sell
268,948
-107,432
-29% -$6.45M 0.11% 195
2020
Q2
$22.6M Sell
376,380
-38,513
-9% -$2.3M 0.17% 130
2020
Q1
$24.5M Sell
414,893
-306,837
-43% -$18.4M 0.24% 86
2019
Q4
$43.4M Sell
721,730
-157,817
-18% -$9.49M 0.33% 56
2019
Q3
$52.8M Buy
879,547
+316,425
+56% +$19M 0.46% 32
2019
Q2
$33.8M Sell
563,122
-97,979
-15% -$5.89M 0.31% 63
2019
Q1
$39.7M Sell
661,101
-209,721
-24% -$12.6M 0.38% 42
2018
Q4
$52.1M Buy
870,822
+317,744
+57% +$19.1M 0.58% 25
2018
Q3
$33.2M Sell
553,078
-124,514
-18% -$7.47M 0.32% 54
2018
Q2
$40.6M Buy
677,592
+408,541
+152% +$24.5M 0.43% 39
2018
Q1
$16.1M Buy
269,051
+33,972
+14% +$2.04M 0.18% 121
2017
Q4
$14.1M Buy
235,079
+178,409
+315% +$10.7M 0.17% 129
2017
Q3
$3.4M Buy
56,670
+13,320
+31% +$799K 0.05% 367
2017
Q2
$2.6M Buy
43,350
+25,969
+149% +$1.56M 0.04% 421
2017
Q1
$1.04M Buy
17,381
+840
+5% +$50.4K 0.02% 707
2016
Q4
$991K Buy
16,541
+824
+5% +$49.4K 0.02% 681
2016
Q3
$942K Sell
15,717
-115,855
-88% -$6.94M 0.02% 715
2016
Q2
$7.88M Buy
131,572
+114,793
+684% +$6.88M 0.17% 114
2016
Q1
$1M Buy
16,779
+9,009
+116% +$539K 0.02% 573
2015
Q4
$465K Buy
+7,770
New +$465K 0.01% 879

Other funds holding FTSM

Cambridge Investment Research Advisors's FTSM Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its First Trust Enhanced Short Maturity ETF (FTSM) stake by 12% in Q2 2026, selling an estimated $7.52M and leaving 890,633 shares worth $53.2M. The position accounts for 0.12% of the portfolio, ranked #153.

Cambridge Investment Research Advisors first reported a position in FTSM in Q4 2015 and has held it in 43 quarters since. The position peaked at $116M in Q1 2023. 149 funds tracked by Wall St. Rank hold FTSM as of Q2 2026.

  • Cambridge Investment Research Advisors held 890,633 shares of First Trust Enhanced Short Maturity ETF worth $53.2M as of Q2 2026.
  • Cambridge Investment Research Advisors sold 125,579 First Trust Enhanced Short Maturity ETF shares in Q2 2026, an estimated $7.52M.
  • First Trust Enhanced Short Maturity ETF made up 0.12% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #153 holding.
  • Cambridge Investment Research Advisors first reported a position in First Trust Enhanced Short Maturity ETF in Q4 2015 and has held it in 43 quarters since.
  • Cambridge Investment Research Advisors's First Trust Enhanced Short Maturity ETF position peaked at $116M in Q1 2023.
  • 149 funds tracked by Wall St. Rank held First Trust Enhanced Short Maturity ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.